🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Jeffrey La Rosa

Stock Analyst at Leerink Partners

(0.13)
# 4,808
Out of 5,162 analysts
25
Total ratings
23.8%
Success rate
-30.9%
Average return

Stocks Rated by Jeffrey La Rosa

Senti Biosciences Holdings
Dec 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.087
Upside: -
Pyxis Oncology
Aug 15, 2025
Reiterated: Buy
Price Target: $7
Current: $1.41
Upside: n/a
Janux Therapeutics
Aug 12, 2025
Reiterated: Buy
Price Target: $87
Current: $10.31
Upside: n/a
Merck & Co.
Oct 28, 2022
Rated: Buy
Price Target: $112
Current: $137.78
Upside: n/a